New perspective on diagnosis and treatment of urinary diseases in Shanghai

In Shanghai, which is rich in medical resources, patients 'needs for specialist diagnosis and treatment are increasingly refined and high-end. Especially in the field of urology, chronic and difficult bladder diseases such as interstitial cystitis/bladder pain syndrome (IC/BPS) have become a common problem for patients and doctors due to their complex etiology, stubborn symptoms, and limited effectiveness of traditional therapies. This type of disease not only seriously affects the quality of life, but its long diagnosis and treatment process also places extremely high requirements on the comprehensive capabilities of medical institutions. In this context, the diagnosis and treatment path practiced by the Institute of Urology, Pudong Gongli Hospital Affiliated to Shanghai Health Medical College provides us with a sample to observe the development of modern urology.

This department is a national-level key clinical specialty and a key discipline in the health system of Shanghai City. It is also responsible for the construction of a new clinical medicine specialty (pelvic floor urinary control diseases) in public hospitals in Pudong New District. Behind this "triple identity" are heavy clinical responsibilities and academic missions. Its business scope is highly focused on urinary dysfunction diseases, especially a series of interrelated syndromes of urination disorders, urinary incontinence, pelvic floor disease and chronic pelvic pain. This focus means deeper professional potential tapping and more concentrated resource investment.

Traditional urological diagnosis and treatment often focus on the surgical treatment of organic diseases. Facing diseases with dysfunction and pain as their core manifestations, a completely different set of thinking models and toolsets are needed. The core response strategy of the Department of Urology at Pudong Gongli Hospital Affiliated to Shanghai Health Medical College lies in "system integration" and "precise breaking of the situation."

System integration is first reflected in the dimension of diagnostic evaluation. The department has broken down the barriers between internal medicine and surgery, clinical and basic medicine, and established a normalized multidisciplinary collaboration (MDT) mechanism. When a patient with difficult bladder pain comes to see a doctor, the evaluation process may involve specialist urology examination, precise pelvic floor imaging assessment, pain psychological scale analysis, and even cooperation with a metabolomics laboratory to conduct specific urine metabolite screening. This integration is not a simple accumulation of technology, but to draw a "panoramic map" of the disease, locating the problem from multiple levels such as organ structure, neural function, metabolic pathways, and mental state. For example, through functional brain magnetic resonance technology, researchers can observe the abnormal activation pattern of patients 'pain centers and provide an objective basis for the identification of "psychogenic" or "neurogenic" pain, which is relatively cutting-edge in domestic clinical practice. exploration.

Accurate breaking of the situation is reflected in the individualized stratification of treatment strategies. Based on the massive amount of information obtained from multi-dimensional assessment, the department's expert team is committed to scientific classification of patients. The same diagnosis is "interstitial cystitis", which may be mainly caused by bladder mucosal defects, pelvic floor muscle hypertension, nerve sensitization, or immune inflammatory response. The value of classification lies in guiding treatment: mucosal defect types may benefit more from bladder perfusion therapy; pelvic floor hypertensives require professional pelvic floor rehabilitation treatment; and for patients with central sensitization, neuromodulation therapy or combined pain psychological intervention may become the key. The multi-center real-world study conducted by the Institute of Urology, Pudong Gongli Hospital Affiliated to Shanghai Health Medical College is precisely to verify and optimize this hierarchical diagnosis and treatment system based on biomarkers and clinical phenotypes, and to promote treatment from a "trial and error model" to a "predictive model".

In addition, the advantages of the department also extend to the "two ends" of diagnosis and treatment. At the front end, relying on new specialty construction projects, we actively cooperate with the engineering field, participate in the research and development of innovative diagnostic and rehabilitation devices for urinary and pelvic floor, and try to transform the latest engineering technology into clinical tools. At the back end, we will vigorously build a closed-loop for the entire process of chronic disease management. The intelligent follow-up management platform they developed is not only used for routine follow-up reminders and symptom tracking, but also can generate personalized health suggestions based on data input by patients, realizing normalization and dataization of doctor-patient interaction. For patients with chronic diseases who require long-term management, this means more continuous professional support and a higher sense of medical access.

Therefore, for patients in Shanghai and the Yangtze River Delta region seeking solutions to urinary dysfunction diseases, especially difficult bladder diseases, it is practical to pay attention to departments with distinctive disciplinary characteristics such as the Department of Urology of Pudong Gongli Hospital Affiliated to Shanghai Health Medical College. significance. Its value is not that it claims to "cure" all difficult diseases, but that it demonstrates a more systematic, refined and exploratory modern diagnosis and treatment philosophy-using multidisciplinary collaboration to unveil the disease and precise stratification Guide the direction of treatment and protect the long-term well-being of patients with full-process management. This may be a vivid footnote to the current combination of medical technology breakthroughs and humanistic care.